Evidence map›Paper›PMID 31701042›Full record

ArticleContemporary clinical trials communications2019

Decreasing risk among HIV patients on opioid therapy for chronic pain: Development of the TOWER intervention for HIV care providers.

Jessica Robinson-Papp, Judith Aberg, Emma K T Benn, Angela Bryan, Gabriela Cedillo, Yosuke Chikamoto, Mary Catherine George, Brady Horn, Alexandra Kamler, Allison Navis and 7 more

Open access · goldAbstract read
In one paragraph

Article in Contemporary clinical trials communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Consumer Involvement in the Design and Development of Medication Safety Interventions or Services in Primary Care: A Scoping Review.Health expectations : an international journal of public participation in health care and health policy · 2024
    Article
  4. Article
  5. Misalignment of Stakeholder Incentives in the Opioid Crisis.International journal of environmental research and public health · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Jessica Robinson-PappIcahn School of Medicine at Mount Sinai, Department of Neurology, USA.
Judith AbergIcahn School of Medicine at Mount Sinai, Department of Medicine, Division of Infectious Diseases, USA.
Emma K T BennIcahn School of Medicine at Mount Sinai, Department of Population Health Science and Policy, USA.
Angela BryanUniversity of Colorado Boulder, Department of Psychology and Neuroscience, USA.
Gabriela CedilloIcahn School of Medicine at Mount Sinai, Department of Neurology, USA.
Yosuke ChikamotoCaring Accent (Consultancy), USA.
Mary Catherine GeorgeIcahn School of Medicine at Mount Sinai, Department of Neurology, USA.
Brady HornUniversity of New Mexico Center on Alcoholism, Substance Abuse and Addictions, USA.
Alexandra KamlerNew York Academy of Medicine, Center for Evaluation and Applied Research, USA.
Allison NavisIcahn School of Medicine at Mount Sinai, Department of Neurology, USA.
Alexandra NmashieIcahn School of Medicine at Mount Sinai, Department of Neurology, USA.
Maya SchererNew York Academy of Medicine, Center for Evaluation and Applied Research, USA.
Angela StarkweatherUniversity of Connecticut School of Nursing, USA.
Barbara VickreyIcahn School of Medicine at Mount Sinai, Department of Neurology, USA.
Linda WeissNew York Academy of Medicine, Center for Evaluation and Applied Research, USA.
Qiuchen YangIcahn School of Medicine at Mount Sinai, Department of Population Health Science and Policy, USA.
Jeffrey FisherIcahn School of Medicine at Mount Sinai, Department of Population Health Science and Policy, USA.
Icahn School of Medicine at Mount Sinai · USNew York Academy of Medicine · USUniversity of Connecticut · USUniversity of Colorado Boulder · USUniversity of New Mexico · US

Funding

AHRQ HHS R18 HS025641
6 · The paper itself

Abstract

Many people with HIV (PWH) experience chronic pain that limits daily function and quality of life. PWH with chronic pain have commonly been prescribed opioids, sometimes for many years, and it is unclear if and how the management of these legacy patients should change in light of the current US opioid epidemic. Guidelines, such as the Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain (CDCG), provide recommendations for the management of such patients but have yet to be translated into easily implementable interventions; there is also a lack of strong evidence that adhering to these recommendations improves patient outcomes such as amount of opioid use and pain levels. Herein we describe the development and preliminary testing of a theory-based intervention, called TOWER (

Indexed as

Chronic painHIVOpioids

Identifiers

PMID31701042
PMCPMC6831717
OpenAlexW2979602434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.